Status:
COMPLETED
Extracorporeal Shockwave Therapy for Diabetic Foot Wounds
Lead Sponsor:
Hull University Teaching Hospitals NHS Trust
Collaborating Sponsors:
University of Hull
Conditions:
Diabetic Foot
Wound
Eligibility:
All Genders
18+ years
Brief Summary
Diabetic wounds post digital amputation have poor healing in 30-45% of cases, resulting in 75% of patients undergoing a further amputation within the year, despite best wound management. Extracorpore...
Eligibility Criteria
Inclusion
- Diagnosis of diabetes mellitus
- Open wound of the foot
- ABPI \>0.8
- Age greater than 18 years old
- Able and willing to give written informed consent
- Be able to adhere to protocol and attend all follow up appointments
Exclusion
- Pregnancy or breast-feeding
- Current malignancy
- Allergy to materials used in the treatment
- Palliative
- Unable or unwilling to give consent
- Anticoagulation
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 13 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04042285
Start Date
February 1 2019
End Date
May 13 2022
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hull and East Yorkshire Hospitals NHS Trust
Hull, United Kingdom, HU3 2JZ